These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Toward an antibody-based HIV-1 vaccine. Hoxie JA Annu Rev Med; 2010; 61():135-52. PubMed ID: 19824826 [TBL] [Abstract][Full Text] [Related]
28. HIV Vaccination: A Roadmap among Advancements and Concerns. Trovato M; D'Apice L; Prisco A; De Berardinis P Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671786 [TBL] [Abstract][Full Text] [Related]
29. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination. Martinez DR; Permar SR; Fouda GG Clin Vaccine Immunol; 2016 Feb; 23(2):84-94. PubMed ID: 26656117 [TBL] [Abstract][Full Text] [Related]
30. Recent strategies targeting HIV glycans in vaccine design. Horiya S; MacPherson IS; Krauss IJ Nat Chem Biol; 2014 Dec; 10(12):990-9. PubMed ID: 25393493 [TBL] [Abstract][Full Text] [Related]
31. [Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination]. Vzorov AN; Uryvaev LV Mol Biol (Mosk); 2017; 51(6):945-957. PubMed ID: 29271959 [TBL] [Abstract][Full Text] [Related]
32. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies. Ahmed Y; Tian M; Gao Y AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278 [TBL] [Abstract][Full Text] [Related]
33. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
35. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. Yin J; Dai A; Lecureux J; Arango T; Kutzler MA; Yan J; Lewis MG; Khan A; Sardesai NY; Montefiore D; Ruprecht R; Weiner DB; Boyer JD Vaccine; 2011 Sep; 29(39):6763-70. PubMed ID: 21195801 [TBL] [Abstract][Full Text] [Related]
36. Broadly neutralizing antibodies against HIV-1: templates for a vaccine. van Gils MJ; Sanders RW Virology; 2013 Jan; 435(1):46-56. PubMed ID: 23217615 [TBL] [Abstract][Full Text] [Related]
37. In vivo protection by broadly neutralizing HIV antibodies. van Gils MJ; Sanders RW Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020 [TBL] [Abstract][Full Text] [Related]
38. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Voss JE; Andrabi R; McCoy LE; de Val N; Fuller RP; Messmer T; Su CY; Sok D; Khan SN; Garces F; Pritchard LK; Wyatt RT; Ward AB; Crispin M; Wilson IA; Burton DR Cell Rep; 2017 Oct; 21(1):222-235. PubMed ID: 28978475 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic vaccination for HIV: hopes and challenges. Stephenson KE Curr Opin HIV AIDS; 2018 Sep; 13(5):408-415. PubMed ID: 29957615 [TBL] [Abstract][Full Text] [Related]